[OpenAI Researcher Starts AI Drug Discovery Venture, Valuation Reaches $2 Billion] According to monitoring by Beating and as reported by TechCrunch citing informed sources, OpenAI researcher Miles Wang is set to leave and start his own venture. Previously, he worked at OpenAI researching how AI can accelerate scientific and biological discoveries. The new team plans to develop AI models for drug discovery, and several OpenAI researchers may join. The team is reportedly in talks to raise approximately $200 million in funding, with a valuation of around $2 billion. Lightspeed is likely to lead the investment. The project may focus on finding new uses for old drugs and clinically failed drugs. [Original Link]